GSK is conducting Phase II and Ib clinical trials for ispinesib and a Phase I clinical trial of SB – 743921 and Cytokinetics is a phase I / II trial of SB – 743921 in non-Hodgkin’s lymphoma. Unpartnered Cytokinetics ‘ cardiovascular disease program is to use the second program, the company’s expertise in cytoskeletal pharmacology. Cytokinetics recently completed a Phase I clinical trial of CK – 1827452, A novel small molecule cardiac myosin activator for the intravenous treatment of heart failure and also preceded CK as a potential as a potential drug candidates for the treatment of chronic heart failure via oral administration For more information about Cytokinetics can be obtained.
‘We welcome the Government’s commitment to a real – terms increase in NHS funding, however , the reality is that this small increase in a time of rising demand and rising costs. Health care will still feel like a cut. Read the rest of this entry »